Recent Analyst Forecasts and Stock Ratings
Amicus Therapeutics, Inc. FAQ's
Amicus Therapeutics, Inc. has been rated by research analysts at Cantor Fitzgerald, Needham, Bank of America Securities, Guggenheim, Morgan Stanley, Goldman Sachs in the past 90 days.